Huntington’s disease occurs in patients who inherit a mutant form of a protein called Huntingtin (Htt). The protein was first identified in 1993, but how it leads to disease is still poorly understood. One paradox is that the Htt protein is present throughout the body, yet the damage it causes is largely concentrated within specific populations of neurons in the striatum – a brain region also implicated in Parkinson’s disease and other disorders.
The MIT team led by Ann Graybiel, an Institute Professor and member of the McGovern Institute for Brain Research, focused on a gene known as CalDAG-GEFI, which is particularly enriched in the striatal neurons that die in Huntington’s disease. The MIT team showed that CalDAG-GEFI is dramatically down-regulated in the brains of individuals with Huntington’s disease as well as in mouse models of the disease. By following mutant mice for up to 9 months, the researchers showed that this reduction occurs gradually, in parallel with the progression of the disease.
These progressive changes suggest that CalDAG-GEFI is likely to play some role in the disease process. The researchers wanted to determine whether the suppression of this gene is part of the death process, or whether it represents part of the brain’s protective response. They found that the latter explanation appears to be true – when the researchers artificially blocked the expression of CalDAG-GEFI (using a method known as siRNA), the striatal neurons were protected from Htt –induced damage.
“So the enriched expression of CalDAG-GEFI in the striatum may explain, in part, why striatal neurons are particularly vulnerable to the expression of mutant Htt,” explained first author and research scientist, Jill Crittenden of the McGovern Institute for Brain Research. “Switching off of the CalDAG-GEFI gene may represent the neuron’s attempt, ultimately unsuccessful, to save itself.”
Huntington’s disease is currently incurable, and existing treatments address only the symptoms, and have no effect on the course of the disease or its eventual fatal outcome. The researchers hope that by understanding the molecular pathway by which neurons are killed, their findings may suggest new strategies for the development of treatments that could slow or even prevent the progression of the disease.
Source: Crittenden J, Dunn DE, Merali FI, Woodman B, Yim M, Borkowska AE, Frosch MP, Bates GP,Housman DE, Lo DC, Graybiel AM. CalDAG-GEFI Down-regulation in the striatum as a neuroprotective change in Huntington’s Disease. Human Molecular Genetics. 10 February 2010.
Funding: Institute of Child Health and Development, James W. and Patricia T. Poitras Major Mental Illness Research Fund, National Institutes of Mental Health, Wellcome Trust, Cure Huntington’s Disease Initiative, Inc., Hereditary Disease Foundation, Neuropathology Cores of the Massachusetts Alzheimer Disease Research Center, MGH/MIT Morris Udall Center of Excellence in Parkinson Disease Research, and the McGovern Institute for Brain Research at MITJen Hirsch
Jen Hirsch | Newswise Science News
Separating methane and CO2 will become more efficient
18.10.2017 | KU Leuven
Bolstering fat cells offers potential new leukemia treatment
17.10.2017 | McMaster University
University of Maryland researchers contribute to historic detection of gravitational waves and light created by event
On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...
Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.
Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....
Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).
When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...
Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.
How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...
Scientists from the Max Planck Institute of Quantum Optics, using high precision laser spectroscopy of atomic hydrogen, confirm the surprisingly small value of the proton radius determined from muonic hydrogen.
It was one of the breakthroughs of the year 2010: Laser spectroscopy of muonic hydrogen resulted in a value for the proton charge radius that was significantly...
17.10.2017 | Event News
10.10.2017 | Event News
10.10.2017 | Event News
18.10.2017 | Health and Medicine
18.10.2017 | Life Sciences
17.10.2017 | Life Sciences